{
  "timestamp": "20250104_022725",
  "model": "gpt-4o",
  "interaction_type": "answer_normal_rag",
  "question_id": "d88f90a2",
  "question_text": "Drug of choice for relapsing remitting multiple sclerosis is:",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert making decisions based on retrieved medical knowledge."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in the field of Pharmacology.Please help answer this multiple choice question:\n\n    Question: Drug of choice for relapsing remitting multiple sclerosis is:\n\n    Options:\n    opa. Alpha IEN\nopb. Beta IFN\nopc. Gamma IFN\nopd. Natalizumab\n\n### Retrieved Similar Medical Knowledge:\n- Anti-Anxiety Agents PREVENTS Dysautonomia\n- Interferon beta therapy TREATS Multiple Sclerosis, Relapsing-Remitting\n- Disseminated histoplasmosis CAUSES Hypercalcemia\n- Subcortical gray matter LOCATION_OF Atrophic\n- interferon-beta|IFNA1 TREATS Posterior reversible encephalopathy syndrome\n- ergocalciferol ASSOCIATED_WITH cardiovascular risk factor\n- natalizumab TREATS Multiple sclerosis relapse\n- Tumor tissue sample LOCATION_OF Blood Vessel Density\n\n    ### Instructions:\n            - Use standard medical knowledge as the primary guide.\n            - Consider enhanced information only if it aligns with consensus.\n            - If conflicting or unclear, present the most likely correct answer based on known facts.\n            - It's acceptable to show moderate confidence if the question is complex, but still choose one best answer.\n    ### Task:\n                1. Identify the core medical principle and the most likely correct option based on consensus.\n                2. If the evidence is not perfectly clear, pick the best-supported option and explain the reasoning.\n                3. Provide a final analysis and a confidence score (0-100%).\n                \n    ### Output Format\n    Provide your response in valid JSON format:\n    {   \n        \"final_analysis\": \"Your analysis of how the retrieved relationships support the answer\",\n        \"answer\": \"Option key from the available options (only key, like opa)\",\n        \"confidence\": Score between 0-100 based on evidence strength and relevance\n    }\n    "
    }
  ],
  "response": "```json\n{\n    \"final_analysis\": \"Interferon beta (Beta IFN) is a well-established first-line treatment for relapsing-remitting multiple sclerosis (RRMS). It is supported by extensive clinical use and guidelines as a disease-modifying therapy for this condition. Natalizumab is also used for RRMS, particularly in cases where patients do not respond to first-line treatments or have more aggressive disease. However, Beta IFN is more commonly recognized as the initial drug of choice for RRMS.\",\n    \"answer\": \"opb\",\n    \"confidence\": 90\n}\n```",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": true,
    "has_enhanced_info": true,
    "model_config": "gpt-4o",
    "temperature": 0.0
  }
}